{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:24:14Z","timestamp":1790522654024,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["WA1441\/22-1 and 2"],"award-info":[{"award-number":["WA1441\/22-1 and 2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ejphar.2018.05.031","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T16:19:16Z","timestamp":1526919556000},"page":"116-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Decarboxylation of Ang-(1\u20137) to Ala1-Ang-(1\u20137) leads to significant changes in pharmacodynamics"],"prefix":"10.1016","volume":"833","author":[{"given":"Anja","family":"Tetzner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Naughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Gebolys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Eichhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"Villaca\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Walther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejphar.2018.05.031_bib1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/sj.bjp.0707293","article-title":"Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain","volume":"151","author":"Beyermann","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.ejphar.2018.05.031_bib2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.yexcr.2012.02.023","article-title":"Recent advances involving the renin-angiotensin system","volume":"318","author":"Crowley","year":"2012","journal-title":"Exp. Cell Res."},{"issue":"6655","key":"10.1016\/j.ejphar.2018.05.031_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/36362","article-title":"Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A","volume":"390","author":"Daaka","year":"1997","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ejphar.2018.05.031_bib4","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0026-895X(25)08769-3","article-title":"Suramin analogues as subtype-selective G protein inhibitors","volume":"49","author":"Freissmuth","year":"1996","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2018.05.031_bib5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/nar\/gkg103","article-title":"GPCRDB information system for G protein-coupled receptors","volume":"31","author":"Horn","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.ejphar.2018.05.031_bib6","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jcc.20634","article-title":"A semiempirical free energy force field with charge-based desolvation","volume":"28","author":"Huey","year":"2007","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2018.05.031_bib7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/01.ATV.0000253889.09765.5f","article-title":"Mass-spectrometric identification of a novel angiotensin peptide in human plasma","volume":"27","author":"Jankowski","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.ejphar.2018.05.031_bib8","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejphar.2018.05.031_bib9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/01.RES.87.8.705","article-title":"Beta(2)-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both G(s) and G(i)","volume":"87","author":"Kilts","year":"2000","journal-title":"Circ. Res."},{"issue":"17","key":"10.1016\/j.ejphar.2018.05.031_bib10","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1021\/jo00931a001","article-title":"Isolation and structural elucidation of allamandin, an antileukemic iridoid lactone from Allamanda cathartica","volume":"39","author":"Kupchan","year":"1974","journal-title":"J. Org. Chem."},{"issue":"8","key":"10.1016\/j.ejphar.2018.05.031_bib11","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCRESAHA.113.301077","article-title":"Discovery and characterization of alamandine: a novel component of the renin-angiotensin system","volume":"112","author":"Lautner","year":"2013","journal-title":"Circ. Res."},{"issue":"13","key":"10.1016\/j.ejphar.2018.05.031_bib12","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/bph.12955","article-title":"Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP","volume":"172","author":"Mcgrath","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejphar.2018.05.031_bib13","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.108.184911","article-title":"Angiotensin (1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart","volume":"103","author":"Mercure","year":"2008","journal-title":"Circ. Res."},{"issue":"48","key":"10.1016\/j.ejphar.2018.05.031_bib14","doi-asserted-by":"crossref","first-page":"14348","DOI":"10.1021\/bi0258602","article-title":"Residues 293 and 294 are ligand contact points of the human angiotensin type 1 receptor","volume":"41","author":"Perodin","year":"2002","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.ejphar.2018.05.031_bib15","doi-asserted-by":"crossref","first-page":"e65307","DOI":"10.1371\/journal.pone.0065307","article-title":"Differential mechanisms of activation of the Ang peptide receptors AT1, AT2, and MAS: using in silico techniques to differentiate the three receptors","volume":"8","author":"Prokop","year":"2013","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.ejphar.2018.05.031_bib16","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.ejphar.2018.05.031_bib17","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0002-9440(10)63422-0","article-title":"Effects of angiotensin II receptor signaling during skin wound healing","volume":"165","author":"Takeda","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.ejphar.2018.05.031_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/HYPERTENSIONAHA.116.07572","article-title":"G-protein-coupled receptor MrgD is a receptor for angiotensin-(1-7) involving adenylyl cyclase, cAMP, and phosphokinase A","volume":"68","author":"Tetzner","year":"2016","journal-title":"Hypertension"},{"issue":"17","key":"10.1016\/j.ejphar.2018.05.031_bib19","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.ejphar.2018.05.031_bib20","doi-asserted-by":"crossref","first-page":"11867","DOI":"10.1074\/jbc.273.19.11867","article-title":"Sustained long term potentiation and anxiety in mice lacking the Mas protooncogene","volume":"273","author":"Walther","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2018.05.031_bib21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCHEARTFAILURE.109.905968","article-title":"Circulating rather than cardiac angiotensin-(1-7) stimulates cardioprotection after myocardial infarction","volume":"3","author":"Wang","year":"2010","journal-title":"Circ. Heart Fail."},{"issue":"1","key":"10.1016\/j.ejphar.2018.05.031_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/01.RES.84.1.43","article-title":"Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes","volume":"84","author":"Xiao","year":"1999","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2018.05.031_bib23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1124\/mol.54.2.322","article-title":"Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes","volume":"47","author":"Xiao","year":"1995","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejphar.2018.05.031_bib24","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/HYPERTENSIONAHA.110.161836","article-title":"Pressor and renal hemodynamic effects of the novel angiotensin A peptide are angiotensin II type 1A receptor dependent","volume":"57","author":"Yang","year":"2011","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.ejphar.2018.05.031_bib25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/HJH.0b013e3283343250","article-title":"Renal vasoconstrictor and pressor responses to angiotensin IV in mice are AT1a-receptor mediated","volume":"28","author":"Yang","year":"2010","journal-title":"J. Hypertens."},{"issue":"1","key":"10.1016\/j.ejphar.2018.05.031_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.mce.2012.11.006","article-title":"Chimeric natriuretic peptide ACNP stimulates both natriuretic peptide receptors, the NPRA and NPRB","volume":"366","author":"Zhu","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.ejphar.2018.05.031_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuron.2004.12.015","article-title":"Topographically distinct epidermal nociceptive circuits revealed by axonal tracers targeted to MRGPRD","volume":"45","author":"Zylka","year":"2005","journal-title":"Neuron"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918302966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918302966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T17:21:09Z","timestamp":1751649669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918302966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":27,"alternative-id":["S0014299918302966"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.05.031","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decarboxylation of Ang-(1\u20137) to Ala1-Ang-(1\u20137) leads to significant changes in pharmacodynamics","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}